alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › renin-angiotensin-system

renin-angiotensin-system

2 studies tagged renin-angiotensin-system, dated 2007-04-01 to 2015-09-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Modulation of Renin-Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer's Disease 2015-09-01
  2. Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease? 2007-04-01

Studies

2 studies carry this tag.

Date range

2007 to 2015

Top journals

  • Journal of the American Geriatrics Society 1
  • The Lancet. Neurology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Modulation of Renin-Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer's Disease

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Journal of the American Geriatrics Society 2015-09-01 Drug development

    RAS-acting medication users were less likely to convert to AD.

  2. Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. The Lancet. Neurology 2007-04-01 Drug development

    Alzheimer's disease, the most common cause of dementia, is characterised in part by the deposition of amyloid beta protein (Abeta) in the brain.

All topic tags with their study counts